Jennifer Dumoulin

Compassionate Use of Bedaquiline for the Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: Interim Analysis of a French Cohort

Lorenzo Guglielmetti, D. Le Dû, M. Jachym et al. · Clinical Infectious Diseases · 2014 · 186 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Predictive role of plasmatic biomarkers in advanced non-small cell lung cancer treated by nivolumab

Adrien Costantini, Catherine Julié, Coraline Duménil et al. · OncoImmunology · 2018 · 173 citations · Full text

Medicine, Immunology, Oncology +17

Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial

Aurélien Dinh, Jacques Ropers, Clara Duran et al. · The Lancet · 2021 · 162 citations

Pharmacy, Pharmacotherapy, Antimicrobial Pharmacotherapy +13

Role of antibiotic use, plasma citrulline and blood microbiome in advanced non-small cell lung cancer patients treated with nivolumab

Julia Ouaknine Krief, Pierre Helly de Tauriers, Coraline Duménil et al. · Journal for ImmunoTherapy of Cancer · 2019 · 97 citations · Full text

Life Sciences, Immunology, Oncology +16

Circulating tumor DNA evaluated by Next-Generation Sequencing is predictive of tumor response and prolonged clinical benefit with nivolumab in advanced non-small cell lung cancer

Etienne Giroux‐Leprieur, Guillaume Herbretau, Coraline Duménil et al. · OncoImmunology · 2018 · 84 citations · Full text

Medicine, Molecular Medicine, Oncology +17